ArticleNEJM evidence2023
Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.
Jae H Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papertrialcites it
ArticleNEJM evidence2023
Jae H Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.